{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:46:27Z","timestamp":1771515987100,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003194","name":"Agent\u00fara Ministerstva \u0160kolstva, Vedy, V\u00fdskumu a \u0160portu SR","doi-asserted-by":"publisher","award":["1\/0338\/17"],"award-info":[{"award-number":["1\/0338\/17"]}],"id":[{"id":"10.13039\/501100003194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003194","name":"Agent\u00fara Ministerstva \u0160kolstva, Vedy, V\u00fdskumu a \u0160portu SR","doi-asserted-by":"publisher","award":["030UK-4\/2019"],"award-info":[{"award-number":["030UK-4\/2019"]}],"id":[{"id":"10.13039\/501100003194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10840-021-00972-6","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:06:04Z","timestamp":1615421164000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7237-3223","authenticated-orcid":false,"given":"Allan","family":"Bohm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubos","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubomira","family":"Tothova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ljuba","family":"Bacharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Musil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kyselovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Michalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Uher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branislav","family":"Bezak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Olejnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hatala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"7","key":"972_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1253\/circj.67.567","volume":"67","author":"F Morady","year":"2003","unstructured":"Morady F. Treatment of paroxysmal atrial fibrillation by pulmonary vein isolation. Circ J. 2003;67(7):567\u201371. https:\/\/doi.org\/10.1253\/circj.67.567.","journal-title":"Circ J"},{"issue":"1","key":"972_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10840-012-9744-8","volume":"36","author":"KL Looi","year":"2013","unstructured":"Looi KL, Gajendragadkar P, Taha T, Elsik M, Scully E, Heck P, et al. Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2013;36(1):61\u20139; discussion 9. https:\/\/doi.org\/10.1007\/s10840-012-9744-8.","journal-title":"J Interv Card Electrophysiol"},{"issue":"3","key":"972_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10840-012-9723-0","volume":"35","author":"N Assasi","year":"2012","unstructured":"Assasi N, Xie F, Blackhouse G, Gaebel K, Robertson D, Hopkins R, et al. Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol. 2012;35(3):259\u201375. https:\/\/doi.org\/10.1007\/s10840-012-9723-0.","journal-title":"J Interv Card Electrophysiol"},{"issue":"4","key":"972_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCEP.115.003095","volume":"8","author":"M Das","year":"2015","unstructured":"Das M, Wynn GJ, Morgan M, Lodge B, Waktare JE, Todd DM, et al. Recurrence of atrial tachyarrhythmia during the second month of the blanking period is associated with more extensive pulmonary vein reconnection at repeat electrophysiology study. Circ Arrhythm Electrophysiol. 2015;8(4):846\u201352.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"972_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.acvd.2017.07.002","volume":"111","author":"R Bacquelin","year":"2018","unstructured":"Bacquelin R, Martins RP, Behar N, Galand V, Polin B, Lacaze J, et al. A novel method for localization and ablation of conduction gaps after wide antral circumferential ablation of pulmonary veins. Arch Cardiovasc Dis. 2018;111(5):340\u20138. https:\/\/doi.org\/10.1016\/j.acvd.2017.07.002.","journal-title":"Arch Cardiovasc Dis"},{"issue":"5","key":"972_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jjcc.2015.04.002","volume":"66","author":"CA Goudis","year":"2015","unstructured":"Goudis CA, Korantzopoulos P, Ntalas IV, Kallergis EM, Ketikoglou DG. Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links. J Cardiol. 2015;66(5):361\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2015.04.002.","journal-title":"J Cardiol"},{"issue":"6","key":"972_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jjcc.2019.12.012","volume":"75","author":"T Takagi","year":"2020","unstructured":"Takagi T, Nakamura K, Hashimoto H, Asami M, Ishii R, Enomoto Y, et al. The impact of sleep apnea on right atrial structural remodeling with atrial fibrillation. J Cardiol. 2020;75(6):665\u201372. https:\/\/doi.org\/10.1016\/j.jjcc.2019.12.012.","journal-title":"J Cardiol"},{"issue":"4","key":"972_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/europace\/eus027","volume":"14","author":"H Calkins","year":"2012","unstructured":"Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528\u2013606. https:\/\/doi.org\/10.1093\/europace\/eus027.","journal-title":"Europace."},{"issue":"11","key":"972_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1540-8167.2010.01798.x","volume":"21","author":"EM Balk","year":"2010","unstructured":"Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol. 2010;21(11):1208\u201316. https:\/\/doi.org\/10.1111\/j.1540-8167.2010.01798.x.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"972_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.amjcard.2012.04.028","volume":"110","author":"EK Heist","year":"2012","unstructured":"Heist EK, Chalhoub F, Barrett C, Danik S, Ruskin JN, Mansour M. Predictors of atrial fibrillation termination and clinical success of catheter ablation of persistent atrial fibrillation. Am J Cardiol. 2012;110(4):545\u201351. https:\/\/doi.org\/10.1016\/j.amjcard.2012.04.028.","journal-title":"Am J Cardiol"},{"issue":"11","key":"972_CR11","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.hrthm.2015.07.003","volume":"12","author":"J Kosiuk","year":"2015","unstructured":"Kosiuk J, Dinov B, Kornej J, Acou WJ, Schonbauer R, Fiedler L, et al. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. Heart Rhythm. 2015;12(11):2207\u201312. https:\/\/doi.org\/10.1016\/j.hrthm.2015.07.003.","journal-title":"Heart Rhythm"},{"issue":"11","key":"972_CR12","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.hrthm.2016.07.018","volume":"13","author":"RA Winkle","year":"2016","unstructured":"Winkle RA, Jarman JW, Mead RH, Engel G, Kong MH, Fleming W, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016;13(11):2119\u201325. https:\/\/doi.org\/10.1016\/j.hrthm.2016.07.018.","journal-title":"Heart Rhythm"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2018.08.018","volume":"276","author":"TS Potpara","year":"2019","unstructured":"Potpara TS, Mujovic N, Sivasambu B, Shantsila A, Marinkovic M, Calkins H, et al. Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation. Int J Cardiol. 2019;276:130\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.018.","journal-title":"Int J Cardiol"},{"key":"972_CR14","doi-asserted-by":"publisher","unstructured":"Sano M, Heeger C-H, Sciacca V, Gro\u00dfe N, Keelani A, Fahimi BHH, et al. Evaluation of predictive scores for late and very late recurrence after cryoballoon-based ablation of atrial fibrillation. J Interv Card Electrophysiol. 2020. https:\/\/doi.org\/10.1007\/s10840-020-00778-y.","DOI":"10.1007\/s10840-020-00778-y"},{"issue":"8","key":"972_CR15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1253\/circj.cj-09-0999","volume":"74","author":"YK Lin","year":"2010","unstructured":"Lin YK, Lin FZ, Chen YC, Cheng CC, Lin CI, Chen YJ, et al. Oxidative stress on pulmonary vein and left atrium arrhythmogenesis. Circ J. 2010;74(8):1547\u201356. https:\/\/doi.org\/10.1253\/circj.cj-09-0999.","journal-title":"Circ J"},{"issue":"3","key":"972_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10840-013-9867-6","volume":"39","author":"N Sasaki","year":"2014","unstructured":"Sasaki N, Okumura Y, Watanabe I, Mano H, Nagashima K, Sonoda K, et al. Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation. J Interv Card Electrophysiol. 2014;39(3):241\u20139. https:\/\/doi.org\/10.1007\/s10840-013-9867-6.","journal-title":"J Interv Card Electrophysiol"},{"issue":"3","key":"972_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jelectrocard.2016.03.007","volume":"49","author":"A B\u00f6hm","year":"2016","unstructured":"B\u00f6hm A, Tothova L, Urban L, Slezak P, Bacharova L, Musil P, et al. The relation between oxidative stress biomarkers and atrial fibrillation after pulmonary veins isolation. J Electrocardiol. 2016;49(3):423\u20138. https:\/\/doi.org\/10.1016\/j.jelectrocard.2016.03.007.","journal-title":"J Electrocardiol"},{"issue":"1-2","key":"972_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clinbiochem.2014.09.023","volume":"48","author":"M Karlik","year":"2015","unstructured":"Karlik M, Valkovic P, Hancinova V, Krizova L, Tothova L, Celec P. Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis. Clin Biochem. 2015;48(1-2):24\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.09.023.","journal-title":"Clin Biochem"},{"issue":"10","key":"972_CR19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jacep.2017.04.003","volume":"3","author":"A Bj\u00f6rkenheim","year":"2017","unstructured":"Bj\u00f6rkenheim A, Brandes A, Magnuson A, Chemnitz A, Svedberg L, Edvardsson N, et al. Assessment of atrial fibrillation\u2013specific symptoms before and 2 years after atrial fibrillation ablation: do patients and physicians differ in their perception of symptom relief? JACC Clin Electrophysiol. 2017;3(10):1168\u201376. https:\/\/doi.org\/10.1016\/j.jacep.2017.04.003.","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"972_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1540-8167.2010.01923.x","volume":"22","author":"E Pokushalov","year":"2011","unstructured":"Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Turov A, Shirokova N, et al. Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring. J Cardiovasc Electrophysiol. 2011;22(4):369\u201375.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"972_CR21","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Heart Rhythm. 2017;14(10):e445\u2013e94. https:\/\/doi.org\/10.1016\/j.hrthm.2017.07.009.","journal-title":"Heart Rhythm"},{"issue":"10","key":"972_CR22","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1253\/circj.CJ-12-1099","volume":"76","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Kume O, Wakisaka O, Fukunaga N, Teshima Y, Hara M, et al. Novel strategy to prevent atrial fibrosis and fibrillation. Circ J. 2012;76(10):2318\u201326. https:\/\/doi.org\/10.1253\/circj.CJ-12-1099.","journal-title":"Circ J"},{"issue":"4","key":"972_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0891-5849(99)00264-6","volume":"28","author":"LJ Roberts","year":"2000","unstructured":"Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28(4):505\u201313. https:\/\/doi.org\/10.1016\/s0891-5849(99)00264-6.","journal-title":"Free Radic Biol Med"},{"key":"972_CR24","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev. 2014;2014:360438\u20131. https:\/\/doi.org\/10.1155\/2014\/360438.","journal-title":"Oxidative Med Cell Longev"},{"issue":"4","key":"972_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00043798-200108000-00006","volume":"8","author":"EF Schisterman","year":"2001","unstructured":"Schisterman EF, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P, et al. TBARS and cardiovascular disease in a population-based sample. J Cardiovasc Risk. 2001;8(4):219\u201325.","journal-title":"J Cardiovasc Risk"},{"issue":"6","key":"972_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jjcc.2015.12.007","volume":"68","author":"T Soeki","year":"2016","unstructured":"Soeki T, Matsuura T, Bando S, Tobiume T, Uematsu E, Ise T, et al. Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. J Cardiol. 2016;68(6):472\u20137. https:\/\/doi.org\/10.1016\/j.jjcc.2015.12.007.","journal-title":"J Cardiol"},{"issue":"18","key":"972_CR27","first-page":"4147","volume":"21","author":"L Lin","year":"2017","unstructured":"Lin L, Zhao GJ, Qin LL. Association between advanced oxidation protein products (AOPP) and vascular calcification in uremic patients. Eur Rev Med Pharmacol Sci. 2017;21(18):4147\u201352.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"972_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/circulationaha.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597\u2013605. https:\/\/doi.org\/10.1161\/circulationaha.106.621854.","journal-title":"Circulation."},{"issue":"3","key":"972_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ijcard.2011.05.072","volume":"157","author":"S Raposeiras-Roubin","year":"2012","unstructured":"Raposeiras-Roubin S, Rodino-Janeiro BK, Grigorian-Shamagian L, Seoane-Blanco A, Moure-Gonzalez M, Varela-Roman A, et al. Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol. 2012;157(3):397\u2013402. https:\/\/doi.org\/10.1016\/j.ijcard.2011.05.072.","journal-title":"Int J Cardiol"},{"issue":"9","key":"972_CR30","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1253\/circj.CJ-19-0618","volume":"83","author":"S-i Yamagishi","year":"2019","unstructured":"Yamagishi S-i. Role of advanced glycation endproduct (AGE)-receptor for advanced glycation endproduct (RAGE) axis in cardiovascular disease and its therapeutic intervention. Circ J. 2019;83(9):1822\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-19-0618.","journal-title":"Circ J"},{"issue":"23","key":"972_CR31","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehm486","volume":"28","author":"JWL Hartog","year":"2007","unstructured":"Hartog JWL, Voors AA, Schalkwijk CG, Scheijen J, Smilde TDJ, Damman K, et al. Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J. 2007;28(23):2879\u201385. https:\/\/doi.org\/10.1093\/eurheartj\/ehm486.","journal-title":"Eur Heart J"},{"issue":"6","key":"972_CR32","doi-asserted-by":"publisher","first-page":"26b","DOI":"10.1016\/0002-9149(93)90142-y","volume":"71","author":"TJ Lyons","year":"1993","unstructured":"Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol. 1993;71(6):26b\u201331b. https:\/\/doi.org\/10.1016\/0002-9149(93)90142-y.","journal-title":"Am J Cardiol"},{"issue":"11","key":"972_CR33","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/europace\/euv449","volume":"18","author":"PS Yang","year":"2016","unstructured":"Yang PS, Kim TH, Uhm JS, Park S, Joung B, Lee MH, et al. High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient. Europace. 2016;18(11):1711\u20138. https:\/\/doi.org\/10.1093\/europace\/euv449.","journal-title":"Europace."},{"issue":"13","key":"972_CR34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/1389557519666190311140737","volume":"19","author":"SI Yamagishi","year":"2019","unstructured":"Yamagishi SI, Sotokawauchi A, Matsui T. Pathological role of advanced glycation end products (AGEs) and their receptor axis in atrial fibrillation. Mini-Rev Med Chem. 2019;19(13):1040\u20138. https:\/\/doi.org\/10.2174\/1389557519666190311140737.","journal-title":"Mini-Rev Med Chem"},{"issue":"3","key":"972_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/circulationaha.104.518837","volume":"112","author":"G Hindricks","year":"2005","unstructured":"Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005;112(3):307\u201313. https:\/\/doi.org\/10.1161\/circulationaha.104.518837.","journal-title":"Circulation."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-00972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-021-00972-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-00972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T06:08:27Z","timestamp":1656310107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-021-00972-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s10840-021-00972-6","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Springer Nature\u2019s version of this paper was updated to reflect the correct affiliation 2.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Ethics Committee of the National Institute of Cardiovascular Diseases, Bratislava, Slovakia. Ethics Committee declares it is organized and operates according to ICH GCP requirements, the ethical principles that have their origin in the Declaration of Helsinki, and applicable laws and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}